Type | Audited |
Date Begin | 01-Jan-22 |
Date End | 31-Mar-22 |
Net Sales | 5.11 |
Other Income | 1.31 |
Total Income | 6.42 |
Expenditure | -6.77 |
Finance Costs | -1.87 |
Other Expenses | -2.34 |
Employee benefit expense | -0.69 |
Depreciation and amortisation expense | -1.64 |
Impairment Loss | -0.24 |
Profit (+)/ Loss (-) from Ordinary Activities before Tax | -0.36 |
Tax | 0.16 |
Net Profit (+)/ Loss (-) from Ordinary Activities after Tax | -0.20 |
Net Profit | -0.20 |
Deferred tax | 0.16 |
Minority Interest | 0.00 |
Share of Profit & Loss of Asso | 0.00 |
Net Profit after Mino Inter & Share of P & L | -0.20 |
Any Other | 0.00 |
Income Attributable to Consolidated Group | -0.20 |
EPS after Extraordinary items (in Rs) | |
Exceptional Item | 0.00 |
Profit after Interest but before Exceptional Items | -0.36 |
Net Profit Loss for the period from continuing operations | -0.20 |
Profit (loss) from discontinuing operations before tax | 0.00 |
Tax expense of discontinuing operations | 0.00 |
Net profit (loss) from discontinuing operation after tax | 0.00 |
Other Comprehensive Income Net of Taxes | 0.00 |
Any Other Comprehensive Item | 0.00 |
Total Comprehensive Income for the Period | -0.20 |
Total Amount of items that will not be reclassified to profit and loss | 0.00 |
Income tax relating to items that will not be reclassified to profit or loss | 0.00 |
Total Amount of items that will be reclassified to profit and loss | 0.00 |
Income tax relating to items that will be reclassified to profit or loss | 0.00 |
Net movement in regulatory deferral account balances | 0.00 |
Share of profit(loss) of associates and joint ventures | 0.00 |
| Notes |